Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life

Clin Drug Investig. 2011; 31(1):51-60

View abstract

Authors

Papp K, Signorovitch J, Ramakrishnan K, Yu AP, Gupta S, Bao Y, Mulani P